CWM
AQST icon

CIBC World Markets’s Aquestive Therapeutics AQST Stock Holding History

CIBC World Markets’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$35.1K Sell
10,601
-5,878
-36% -$16.9K ﹤0.01% 1500
2025
Q1 		$47.8K Buy
+16,479
New +$49.9K ﹤0.01% 1723

Other funds holding AQST

BCM
Bratton Capital Management Fort Worth, Texas $40.7M AUM 43.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.14B AUM 42.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

CIBC World Markets's AQST Position: Q2 2025 in Review

CIBC World Markets reduced its Aquestive Therapeutics (AQST) stake by 36% in Q2 2025, selling an estimated $16.9K and leaving 10,601 shares worth $35.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1500.

CIBC World Markets first reported a position in AQST in Q1 2025 and has held it in 2 quarters since. The position peaked at $47.8K in Q1 2025. 116 funds tracked by Wall St. Rank hold AQST as of Q2 2025.

  • CIBC World Markets held 10,601 shares of Aquestive Therapeutics worth $35.1K as of Q2 2025.
  • CIBC World Markets sold 5,878 Aquestive Therapeutics shares in Q2 2025, an estimated $16.9K.
  • Aquestive Therapeutics made up ﹤0.01% of CIBC World Markets's portfolio in Q2 2025, its #1500 holding.
  • CIBC World Markets first reported a position in Aquestive Therapeutics in Q1 2025 and has held it in 2 quarters since.
  • CIBC World Markets's Aquestive Therapeutics position peaked at $47.8K in Q1 2025.
  • 116 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q2 2025.

Based on CIBC World Markets's 13F filing for Q2 2025, filed 14 Aug 2025.